US Bancorp
INSY

US Bancorp’s Insys Therapeutics, Inc. INSY Stock Holding History

US Bancorp’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-36
Closed – – 3740
2019
Q1 		$0 Hold
36
– – ﹤0.01% 3725
2018
Q4 		$0 Hold
36
– – ﹤0.01% 3776
2018
Q3 		$0 Hold
36
– – ﹤0.01% 3753
2018
Q2 		$0 Hold
36
– – ﹤0.01% 3755
2018
Q1 		$0 Sell
36
-39
-52% -$322 ﹤0.01% 3756
2017
Q4 		$1K Sell
75
-81
-52% -$530 ﹤0.01% 3575
2017
Q3 		$1K Sell
156
-122
-44% -$1.26K ﹤0.01% 3543
2017
Q2 		$4K Sell
278
-1,965
-88% -$23.3K ﹤0.01% 3296
2017
Q1 		$24K Buy
2,243
+195
+10% +$2.08K ﹤0.01% 2787
2016
Q4 		$19K Buy
2,048
+1,226
+149% +$13.9K ﹤0.01% 2862
2016
Q3 		$10K Buy
822
+75
+10% +$1.14K ﹤0.01% 3015
2016
Q2 		$10K Sell
747
-148
-17% -$2.16K ﹤0.01% 3014
2016
Q1 		$14K Sell
895
-1,466
-62% -$27.8K ﹤0.01% 2908
2015
Q4 		$68K Sell
2,361
-14,110
-86% -$391K ﹤0.01% 2286
2015
Q3 		$470K Buy
16,471
+8,306
+102% +$306K ﹤0.01% 1320
2015
Q2 		$294K Buy
+8,165
New +$254K ﹤0.01% 1596
2014
Q4 		– Sell
-500
Closed -$10K – 3667
2014
Q3 		$10K Buy
+500
New +$7.85K ﹤0.01% 3061

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

US Bancorp's INSY Position: Q2 2019 in Review

US Bancorp sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 36 shares.

US Bancorp first reported a position in INSY in Q3 2014 and held it in 17 quarters. The position peaked at $470K in Q3 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • US Bancorp reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • US Bancorp sold 36 Insys Therapeutics, Inc. shares in Q2 2019.
  • US Bancorp first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 17 quarters.
  • US Bancorp's Insys Therapeutics, Inc. position peaked at $470K in Q3 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on US Bancorp's 13F filing for Q2 2019, filed 13 Aug 2019.